In contrast, Zeta, Koc, RalA, and p53 were increased considerably in the perinuclear sites, and the target binding rate revealed that different iTAAs could bind to different original cellular positions in tumor cells after treatment, which could play a unique role in the regulation of tumor cell growth (Table 4). The gene discussed is IGF2BP3; the disease is neoplasm.